search
Back to results

A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children

Primary Purpose

Hematologic Diseases, Neoplasms

Status
Completed
Phase
Phase 1
Locations
Canada
Study Type
Interventional
Intervention
Remifentanil
Remifentanil
Sponsored by
The Hospital for Sick Children
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hematologic Diseases focused on measuring spinal puncture, remifentanil, propofol, anesthesia, dose finding, pediatrics

Eligibility Criteria

4 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Clinical diagnosis of a hemato-oncological disorder Scheduled to undergo a lumbar puncture Aged 4-11 years Male or female Unpremedicated Willing and able to provide informed consent (or informed consent by parents) Exclusion Criteria: Children who are known or suspected to be difficult to ventilate by face mask Children who are deemed medically unfit to receive either of the two study medications Children who are obese (weight for height > 95th percentile, Children who do not have an indwelling intravenous line

Sites / Locations

  • The Hospital for Sick Children

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Propofol 4 mg/kg group

Propofol 2 mg/kg group

Arm Description

First patient in this arm will receive a bolus of propofol 4 mg/kg followed by remifentanil 0.5 mcg/kg. Subsequent patients randomized to this arm will receive propofol 4 mg/kg but the dose of remifentanil will be determined using the Dixon up-and-down method (i.e. based on the response of the previous patient)

First patient in this arm will receive a bolus of propofol 2 mg/kg followed by remifentanil 1 mcg/kg. Subsequent patients randomized to this arm will receive propofol 2 mg/kg but the dose of remifentanil will be determined using the Dixon up-and-down method (i.e. based on the response of the previous patient)

Outcomes

Primary Outcome Measures

Dose of Remifentanil Required to Prevent Movement in Response to Lumbar Puncture Needle Insertion
Minimum effective dose (Dixon methodology) and ED98 required to prevent movement during lumbar puncture needle insertion

Secondary Outcome Measures

Incidence of Adverse Events.

Full Information

First Posted
September 13, 2005
Last Updated
November 18, 2019
Sponsor
The Hospital for Sick Children
search

1. Study Identification

Unique Protocol Identification Number
NCT00213239
Brief Title
A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children
Official Title
The Minimum Effective Dose of Remifentanil When Co-administered With Propofol for Lumbar Puncture in Children: A Dose-finding Study
Study Type
Interventional

2. Study Status

Record Verification Date
November 2019
Overall Recruitment Status
Completed
Study Start Date
September 2005 (undefined)
Primary Completion Date
September 2007 (Actual)
Study Completion Date
January 2008 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital for Sick Children

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will examine whether the combination of two anaesthetic medications, propofol and remifentanil, is suitable for short duration surgical procedures, providing a shorter recovery time and fewer side effects than either drug used alone.
Detailed Description
Propofol is the primary medication used by anesthesiologists at HSC to provide sedation for lumbar puncture. Propofol provides amnesia, anxiolysis, and hypnosis, but because propofol has no analgestic properties patients often respond to the pain of LP needle insertion. To ensure patient immobility, the dose of propofol is often increased, resulting in a duration of action that is excessive for lumbar puncture. Remifentanil is an ultra-short acting opioid which can be used to provide analgesia and sedation for short painful procedures with minimal residual pain. However, when used as the sole agent, remifentanil is associated with a high incidence of respiratory depression and/or arterial oxygen desaturation and does not provide amnesia or anxiolysis. The combination of propofol and remifentanil may be particularly suitable for short duration procedures, providing a shorter recovery time and fewer side effects than either drug used alone. The objective is to determine the minimum effective dose of remifentanil required to prevent movement for insertion of a lumbar puncture needle when co-administered with propofol. The results obtained from this study will be used in a future study of the recovery characteristics of propofol and remifentanil in children undergoing lumbar puncture.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hematologic Diseases, Neoplasms
Keywords
spinal puncture, remifentanil, propofol, anesthesia, dose finding, pediatrics

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
64 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Propofol 4 mg/kg group
Arm Type
Experimental
Arm Description
First patient in this arm will receive a bolus of propofol 4 mg/kg followed by remifentanil 0.5 mcg/kg. Subsequent patients randomized to this arm will receive propofol 4 mg/kg but the dose of remifentanil will be determined using the Dixon up-and-down method (i.e. based on the response of the previous patient)
Arm Title
Propofol 2 mg/kg group
Arm Type
Experimental
Arm Description
First patient in this arm will receive a bolus of propofol 2 mg/kg followed by remifentanil 1 mcg/kg. Subsequent patients randomized to this arm will receive propofol 2 mg/kg but the dose of remifentanil will be determined using the Dixon up-and-down method (i.e. based on the response of the previous patient)
Intervention Type
Drug
Intervention Name(s)
Remifentanil
Intervention Description
The first patient in this group will receive 4 mg/kg propofol and 0.5 ug/kg respectively. The dose of remifentanil in subsequent patients will be determined by the Dixon up-and-down method.
Intervention Type
Drug
Intervention Name(s)
Remifentanil
Intervention Description
The first patient in this group will receive 2 mg/kg propofol and 1.0 ug/kg respectively. The dose of remifentanil in subsequent patients will be determined by the Dixon up-and-down method.
Primary Outcome Measure Information:
Title
Dose of Remifentanil Required to Prevent Movement in Response to Lumbar Puncture Needle Insertion
Description
Minimum effective dose (Dixon methodology) and ED98 required to prevent movement during lumbar puncture needle insertion
Time Frame
Movement measured at the time of lumbar puncture needle insertion.
Secondary Outcome Measure Information:
Title
Incidence of Adverse Events.
Time Frame
Followed for the length of the procedure.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of a hemato-oncological disorder Scheduled to undergo a lumbar puncture Aged 4-11 years Male or female Unpremedicated Willing and able to provide informed consent (or informed consent by parents) Exclusion Criteria: Children who are known or suspected to be difficult to ventilate by face mask Children who are deemed medically unfit to receive either of the two study medications Children who are obese (weight for height > 95th percentile, Children who do not have an indwelling intravenous line
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jason Hayes, MD
Organizational Affiliation
The Hospital for Sick Children, Toronto Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Hospital for Sick Children
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X8
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
18813039
Citation
Hayes JA, Lopez AV, Pehora CM, Robertson JM, Abla O, Crawford MW. Coadministration of propofol and remifentanil for lumbar puncture in children: dose-response and an evaluation of two dose combinations. Anesthesiology. 2008 Oct;109(4):613-8. doi: 10.1097/ALN.0b013e31818629f3.
Results Reference
result

Learn more about this trial

A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children

We'll reach out to this number within 24 hrs